Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment
COVID-19 치료를 위한 잠재적인 약물 표적으로서의 뉴로키닌-1 수용체
Review
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar
[Category] SARS, 신약개발, 치료법, 치료제,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar
[Category] SARS, 신약개발, 치료법, 치료제,
[키워드] alleviate
antagonist
aprepitant
biomedical scientist
boost
Brainstem
clinical
Clinical studies
conducted
Coronavirus infection
Coronavirus treatment
COVID-19
COVID-19 infection
Cytokine storm
Dexamethasone
directions
disease
drug
drug target
Economy
etiology
hour
immune system
Infection
Infectious disease
Inflammation
Neurokinin-1 Receptor antagonist
neuromodulator
neurotransmitter
nociception
novel
Novel coronavirus
Novel coronavirus infection
pandemic
Perspective
receptor antagonist
released
respiratory
Respiratory illness
responsible
substance
substance P
Substance P/ Neurokinin-1 Receptor antagonist.
Symptom
the disease
therapeutic intervention
Treatment
Treatment strategies
treatment strategy
trigeminal nerve
[DOI] 10.1016/j.biopha.2021.112159 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.biopha.2021.112159 PMC 바로가기 [Article Type] Review